Open AccessDAV132, an Adsorbent-Based Product, Protects the Gut Microbiome and Prevents Clostridium difficile Infections During Moxifloxacin Treatments
Author(s) -
Jean de Gunzburg,
Amine Ghozlane,
Annie Ducher,
Xavier Duval,
Étienne Ruppé,
Mark Pulse,
Caroline H. Chilton,
Laurence Armand-Lefèvre,
Élisabeth Chachaty,
Sakina Sayah-Jeanne,
Joël Doré,
Florence Levenez,
Sean Kennedy,
Nicolas Pons,
W. Jason Weiss,
Mark Wilcox,
Antoine Andremont,
S. Dusko Ehrlich
Publication year - 2015
Publication title -
open forum infectious diseases
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.546
H-Index - 35
ISSN - 2328-8957
DOI - 10.1093/ofid/ofv133.477
Subject(s) - moxifloxacin , medicine , clostridium difficile , gut microbiome , pathogenic organism , microbiology and biotechnology , microbiome , clostridium , antibiotics , bioinformatics , immunology , gut flora , bacteria , biology , genetics